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Abstract
Insect viruses have evolved strategies to control the host RNAi antiviral defense mechanism. In 
nature Drosophila C Virus (DCV) infection causes low mortality and persistent infection, whereas 
the closely related Cricket Paralysis Virus (CrPV) causes a lethal infection. We show these viruses 
use different strategies to modulate the host RNAi defense machinery. The DCV RNAi suppressor 
(DCV-1A) binds to long double-stranded RNA (dsRNA) and prevents processing by Dicer2. In 
contrast, the CrPV suppressor (CrPV-1A) interacts with the endonuclease Ago2 and inhibits its 
activity, without affecting the miRNA-Ago1 mediated silencing. The link between viral RNAi 
suppressors and the outcome of infection was examined using recombinant Sindbis viruses 
encoding either CrPV-1A or DCV-1A. Flies infected with Sindbis virus expressing CrPV-1A 
showed a dramatic increase in virus production, spread and mortality. In contrast, Sindbis 
pathogenesis was only modestly increased by expression of DCV- 1A. We conclude that RNAi 
suppressors function as virulence factors.
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Introduction
RNA interference (RNAi) is a highly conserved, post-transcriptional gene expression control 
mechanism involved in a number of critical cellular processes1. In insects and plants, RNAi 
functions as a major antiviral defense mechanism2. In Drosophila, Dicer2, a class III 
dsRNA endonuclease, processes viral dsRNA structures into small interfering RNAs 
(siRNAs). siRNAs assemble into RNA induced silencing complex (RISC) to serve as guides 
for the endonuclease Ago2, which targets the viral RNA for degradation. As a 
countermeasure to RNAi antiviral defense, viruses encode suppressors of RNA silencing 
(VSR) to modulate host antiviral response.
The study of viral RNAi suppressors has provided insights into the mechanistic details of 
siRNA and miRNA (microRNA) production, as well as RISC assembly. A number of 
factors including helicases, double-stranded RNA binding proteins, and endonucleases are 
required for the proper assembly of functional RISC3,4. Accordingly, viral suppressors can 
potentially target any of these factors to circumvent the host RNAi defense. Intriguingly, 
most RNAi suppressors are RNA binding proteins that interact with dsRNA precursors 
and/or siRNAs to inhibit dsRNA processing by Dicer and assembly of RISC5. However, 
some plant viral RNAi suppressors also target components of the RNAi machinery itself. 
For instance, P0 suppressor protein of the plant polerovirus inhibits downstream events in 
RISC assembly by promoting Ago1 degradation6–8. Another plant virus RNAi suppressor, 
Cucumber mosaic virus (CMV) 2b, inhibits both siRNA and miRNA pathway by blocking 
Ago1 cleavage activity9. Furthermore, inhibition of RNA silencing by most plant viral 
suppressors also affects miRNA function, causing developmental abnormalities that may 
contribute to the pathogenic consequences of infection9,10.
Several insect viruses also encode RNAi suppressors2,11. Drosophila C virus (DCV) is a 
positive strand RNA virus within the Dicistroviridae family that infects many strains of D. 
melanogaster and in nature establishes a non-lethal persistent infection12–17. A closely 
related dicistrovirus, Cricket paralysis virus (CrPV), however, produces lethal infections in 
field crickets18 and in fruit fly19. The viral RNA genomes are comprised of two distinct 
open reading frames, termed ORF1 and ORF2, and the expression of both is determined by 
internal ribosome entry site (IRES)-mediated translation initiation20. ORF1 encodes the 
non-structural replication proteins and ORF2 encodes the structural proteins that form the 
viral capsid. Experimental infection by DCV and CrPV is dramatically exacerbated in flies 
with genetic defects lacking the RNAi effector proteins Dicer2 and Ago2, indicating that 
RNAi is a bona fide anti-viral defense mechanism in insects21–23. The differential 
outcomes of DCV and CrPV infections in nature, led us to examine whether these closely 
related viruses employ distinct strategies to control the host antiviral response. We 
previously reported that DCV encodes a dsRNA binding protein, DCV-1A, that suppresses 
RNA silencing by specifically blocking Dicer2 processing of virus dsRNA into siRNAs22. 
On the other hand, the mechanism employed by CrPV to counteract the Drosophila immune 
system has not been established.
Here we show that CrPV encodes a potent VSR, CrPV-1A that interacts with Ago2 and 
inhibits RISC activity. Furthermore, unlike plant virus RNAi suppressors, this hitherto 
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undescribed RNAi inhibitor neither affects the miRNA pathway nor alters the normal 
development and physiology of the animal. Given the distinct pathogenic outcomes 
observed in DCV and CrPV infections in nature, we hypothesized that RNAi suppressors 
may function as virulence factors. Indeed, we found that CrPV and DCV RNAi suppressor 
can modulate the outcome of Sindbis virus infection in flies. Recombinant Sindbis virus 
expressing CrPV-1A increases virus production resulting in high mortality, whereas 
DCV-1A expression resulted in only a modest enhancement of infection. We propose that 
insect virus RNAi suppressors are key modulators of the host immune response that fine-
tune the outcome of infection in line with the evolutionary viral strategy for successful host 
transmission.
Results
CrPV infection blocks RNAi in S2 cells
Drosophila melanogaster deficient in key RNAi endonucleases, Dicer2 and Ago2, are 
highly susceptible to CrPV infection suggesting that the fly RNAi machinery plays an 
essential role in antiviral defense21–23. Therefore, we examined the possibility that CrPV 
may encode a suppressor of RNAi to control the RNA silencing machinery. RNAi 
suppression was analyzed in S2 cells using a dual luciferase reporter system consisting of a 
firefly luciferase (FLuc) expressing plasmid and a specific 200 nt dsRNA targeting the 
firefly luciferase mRNA or a eGFP dsRNA control (Ctrl) (Fig. 1a)22. Drosophila S2 cells 
were either CrPV or mock infected for 24 hour prior to co-transfection with the reporter 
system for RNAi silencing activity. An internal control using renilla luciferase (RLuc) was 
also included in each experiment. In uninfected control cells, we observed efficient silencing 
of firefly luciferase (suppression by a factor of 380) as compared to a control dsRNA. In 
contrast, silencing was completely suppressed in CrPV infected cells (Fig. 1a), indicating 
that CrPV encodes a potent suppressor of RNAi.
The N-terminal region of CrPV ORF1 encodes an RNAi suppressor protein
DCV and CrPV are closely related species within the cripavirus genus of Dicistroviridae 
family. Amino acid sequence alignment between DCV and CrPV indicated a high degree 
(ca. 55%) of identity within open reading frame 1 (ORF1). A dsRNA binding motif (DSRM) 
was previously identified within the N-terminal 99 amino acid region of DCV ORF1, 
spanning residues 25–88, and shown to encode a potent suppressor of RNAi (DCV-1A)22. 
Based on these observations, we set out to determine whether the suppression of RNAi by 
CrPV could be attributed to a DCV-1A-like RNAi suppressor that mapped to the N-terminus 
of CrPV ORF1.
Alignment of DCV and CrPV in this region revealed no substantial homology as compared 
to homologous downstream amino acid sequences, which includes a highly conserved 
octamer sequence DVExNPGP (Fig. 1b). This octamer sequence serves as a signal for co-
translational protein cleavage between the glycine and proline residues in several 
picornaviruses24. We hypothesized that this DVExNPGP sequence may serve a similar 
function during DCV and CrPV polyprotein processing. We previously reported a DSRM 
within sequences upstream of the DVExNPGP site that functions as a potent RNAi 
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suppressor protein in DCV22. We detected a protein with a molecular weight consistent 
with cleavage at the DVExNPGP site in CrPV infected cells by western blot analysis using a 
polyclonal antibody raised against the first 148 N-terminal amino acids of CrPV ORF1 (Fig. 
1c).
Next, we evaluated the ability of the CrPV sequence upstream of the DVExNPGP motif to 
suppress RNAi in S2 cells. Using the dual reporter assay, luciferase (Fluc, Rluc) expression 
plasmids were co-transfected with dsRNA that specifically targets firefly luciferase and 
plasmids encoding C-terminal deletions of the putative CrPV RNAi suppressor protein (N-
terminal 168, 148, 128, or 108 amino acids). Both CrPV-1A168 and CrPV-1A148 
efficiently blocked RNA silencing (Fig.1d). In contrast, CrPV-1A128 and CrPV-1A108 
expression were unable to suppress RNAi (Fig.1d). Hence, the N-terminal 148 amino acids 
of CrPV ORF1 are sufficient to block RNAi in S2 cells. To examine the effects of CrPV-1A 
suppressor in vivo, we generated transgenic flies expressing the CrPV-1A148 protein, the 
inactive CrPV-1A108 fragment, or GFP. In order to monitor the effects of the CrPV-1A148 
suppressor in vivo, these transgenic flies were crossed with flies expressing a hairpin dsRNA 
(inverted repeat) targeting the white gene (IR[white]). The expression of two mini white 
genes would be suppressed by expression of this hairpin dsRNA, thus providing a 
colorimetric readout for RNA silencing. The white gene was efficiently silenced in flies 
expressing GFP and the IR[white] hairpin causing an orange eye color due to the loss of red 
eye pigmentation (Fig. 2a). In contrast, RNA silencing was suppressed in flies expressing 
CrPV-1A148, resulting in expression of the white gene and, thus, a red eye color. Flies 
expressing the inactive CrPV-1A108 were able to suppress the white gene similar to the 
GFP flies (Fig. 2a). Therefore, our observations demonstrate that CrPV-1A148 is a potent 
RNAi suppressor in Drosophila.
To further characterize CrPV-1A148 (herein named CrPV-1A) suppressor, we compared its 
RNAi suppressing efficiency with that of the RNAi suppressor of DCV, DCV-1A99 (herein 
named DCV-1A). Suppression by CrPV-1A and DCV-1A was assessed in transgenic flies 
by measuring the accumulation of red eye pigments in flies expressing each of the RNAi 
suppressor proteins under the control of identical promoters (Fig. 2a). The red eye pigment 
absorbance (OD480) from control flies expressing GFP and IR[white] was defined as 100% 
silencing, and the OD480 value from flies not expressing IR[white] (Fig. 2a, Fig. 1A148 -) 
was defined as the maximum inhibition of silencing. Flies expressing CrPV-1A and 
IR[white] strongly inhibited RNA silencing (14% silencing) thus restored the red eye 
phenotype, whereas DCV-1A expression resulted a modest effect on RNA silencing (50% 
silencing) (Fig. 2a, compare 1A148 with DCV-1A). Control flies expressing CrPV-1A108 
and GFP exhibited maximum silencing induced by the dsRNA hairpin targeting white gene 
(Fig. 2a). Western blot analysis demonstrated that each suppressor protein accumulated to 
similar levels (Supplementary Fig. 1a). Furthermore, the pathogenic effect of DCV infection 
was exacerbated by the expression of CrPV-1A resulting in higher mortality as compared to 
transgenic flies expressing DCV-1A (Fig. 2b). Together, these data indicate that CrPV-1A is 
a more potent RNAi suppressor than DCV-1A.
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CrPV-1A inhibits siRNA function but not the miRNA pathway
In plants, many VSR also interfere with the miRNA pathway and are often associated with 
disease symptoms resembling plant developmental defects25. We, thus, examined whether 
CrPV-1A also inhibits Drosophila the miRNA pathway. We carried out experiments in S2 
cells using a firefly luciferase reporter containing two perfect complementary miR2b 
sequences (antisense) in its 3' untranslated region (UTR)22(Supplementary Fig. 1b). 4A 
firefly luciferase mRNA containing two copies of the miR2b sequence in the opposite 
orientation (sense) was used as a control. S2 cells were co-transfected with firefly luciferase 
miR2b reporter constructs (sense or antisense), a plasmid encoding Renilla luciferase 
(transfection control), and either the CrPV-1A or DCV-1A expressing construct. The ratio of 
luciferase (miR2b antisense/miR2b sense) expression was identical in cells transfected with 
DCV-1A, CrPV-1A, empty vector, and no plasmid control (Fig. 2c). The dynamic range of 
the miR2b reporter assay was determined using anti-sense oligos (ASO) targeting 
endogenous miR2b miRNA. ASO reduced miR2b silencing effect up to 50% compared to 
non-specific ASO control (Fig. 2d). We concluded that CrPV-1A does not affect the miRNA 
gene silencing pathway in S2 cells.
The effect of CrPV-1A on the miRNA pathway was further examined in third instar larvae. 
Transgenic flies expressing CrPV-1A were crossed with transgenic flies containing a bantam 
miRNA sensor construct that allows in vivo imaging of bantam miRNA activity26. A GFP 
reporter containing three copies of a perfect bantam target sequence in its 3’UTR was 
expressed under the control of the tubulin promoter (Supplementary Fig. 1c). Since bantam 
miRNA expression is temporally and spatially regulated in response to patterning cues, the 
expression of GFP will now be under similar control and a characteristic GFP expression 
pattern was observed in wing imaginal discs from transgenic larvae (Fig. 2e, GFP/bantam). 
In contrast, a GFP transgene construct lacking the bantam target sequences showed 
ubiquitous GFP expression in wing imaginal discs (Fig. 2e, GFP). To monitor the effects of 
CrPV-1A on bantam, we used an engrailed-GAL4 driver to express CrPV-1A in the 
posterior compartment of the imaginal discs27. No effect was observed on bantam miRNA-
mediated GFP repression in the presence of CrPV-1A (Fig. 2e, GFP/bantam + CrPV-1A, 
and Supplementary Serial Optical Sections 1 and 2). Additionally, ubiquitous expression of 
CrPV-1A throughout development does not generate any defect in adult flies, further 
suggesting CrPV-1A does not affect the miRNA pathway in the intact animal (not shown). 
Thus, unlike plant virus RNAi suppressors, CrPV-1A does not interfere with the host 
miRNA pathway.
Recently a new class of small RNA called endogenous small interfering RNA (esiRNAs) 
has been described in Drosophila28–30. The esiRNAs derive from repetitive sequence 
elements like retrotransposons and control their replication in somatic cells. To examine 
whether CrPV-1A perturbs the esiRNA pathway, steady state level of three distinct 
retrotransposons 297, mdg1, 41228,29 were analyzed in female adult head of transgenic flies 
expressing functional RNAi suppressor CrPV-1A148, DCV-1A99 and control flies 
expressing non-functional suppressor CrPV-1A108, dsRNA binding mutant DCV-1A-
K73A22. Homozygous Ago2414 mutant flies were used as positive control51 (Fig. 2f). 
Expression of suppressor DCV-1A and CrPV-1A, but not suppressor mutant controls 
Nayak et al. Page 5
Nat Struct Mol Biol. Author manuscript; available in PMC 2013 November 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
significantly increased retrotransposon expression levels, indicating that the virus 
suppressors also inhibit the esiRNA pathway.
The CrPV-1A blocks Ago2 cleavage activity
We next examined the mechanism by which CrPV-1A inhibits RNAi. Since most RNAi 
suppressors bind dsRNA to inhibit silencing5, we first determined whether CrPV-1A binds 
dsRNA. Electrophoretic mobility shift experiments were performed using radio-labeled 
dsRNA (200 bp) or siRNA (21 bp) probes and purified recombinant CrPV-1A or DCV-1A 
(Supplementary Fig. 2a). Consistent with our previous findings22 DCV-1A efficiently 
bound to long dsRNA (Supplementary Fig. 2a, lane 1, left panel) and to a lesser extent to 
siRNA (lane 1, right panel). In contrast, CrPV-1A did not bind dsRNA or siRNA 
(Supplementary Fig. 2a, lanes 2–7 and 9–14). Next, we examined the effect of CrPV-1A on 
Dicer2 activity using an in vitro assay. In S2 cell extracts, dsRNA was efficiently processed 
to 21 bp siRNAs (Fig. 3a, lane 2). Production of siRNA was inhibited by the addition of 
recombinant DCV-1A (Fig. 3a, lane 5), but not by recombinant CrPV-1A or BSA control 
(Fig. 3a, lane 3 and 4). These experiments indicated that CrPV-1A inhibits RNAi at a 
different step than DCV-1A, functioning downstream of siRNA production. Indeed, 
CrPV-1A, unlike DCV-1A, effectively blocked silencing induced by transfection of both 
long dsRNA in S2 cells as well as 21bp siRNA (Supplementary Fig. 2b), supporting a role 
downstream of siRNA production.
siRNAs produced by Dicer2 are incorporated into the RISC to guide mRNA cleavage. Three 
siRNA nucleoprotein (siRNP) complexes occurring during this assembly process can be 
resolved by native gel electrophoresis, including an initiator R1 (R2D2-Dcr2 initiator 
complex/RDI), an intermediate R2 (RISC loading complex/RLC), and an effector R3 (holo-
RISC) complex31–33. We thus employed native gel analysis to examine whether CrPV-1A 
affects RISC assembly. Incubation of radio-labeled siRNA duplex in Drosophila embryo 
extract resulted in formation of R1, R2 and R3 complexes (Fig. 3b, lane 1). The presence of 
CrPV-1A did not affect the assembly of these three complexes (Fig. 3b, lane 3). In contrast, 
addition of DCV-1A inhibited formation of holo-RISC (Fig. 3b, lane 2), yielding two 
intermediate complexes (Fig. 3b, denoted by asterisks). These experiments indicated that 
CrPV-1A does not affect siRNA loading and holo-RISC assembly. Furthermore, we find 
that DCV-1A has a hitherto undescribed function affecting RISC assembly, in addition to its 
previously described function to bind long dsRNA, suggesting that DCV-1A acts at several 
levels to inhibit RNAi function.
Next we tested whether CrPV-1A affects RISC-mediated mRNA cleavage using an in vitro 
target cleavage assay (Fig. 3c)34. S2 extracts, programmed with a FLuc siRNA, or a non-
specific control siRNA, were incubated with a 592 nt radio-labeled cap FLuc mRNA 
substrate. In control reactions, the FLuc mRNA target was efficiently cleaved (5´ product) in 
the presence of a FLuc specific siRNA, as expected (Fig. 3c, compare lane 3 with lanes 1 
and 2). While purified DCV-1A addition had little effect on target cleavage, FLuc mRNA 
cleavage was strongly inhibited upon addition of purified recombinant CrPV-1A (Fig. 3c, 
lane 6, 7 and 8 for CrPV and lanes 10, 11 for DCV). Similarly, cleavage was also inhibited 
in extracts from CrPV-infected S2 cells (Fig. 3c, lane 4 and 5). These experiments 
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demonstrate that CrPV-1A suppresses RNAi by inhibiting RISC activity without affecting 
Dicer processing or RISC assembly.
CrPV-1A interacts with Ago2
We hypothesized that CrPV-1A inhibits RISC activity by associating with one or more 
components of holo-RISC. To examine this possibility, CrPV-1A carrying a C-terminal 
tandem affinity (Flag and His) purification tag (CrPV-1A-3FH) was immunoisolated from 
S2 cells. Western blot analysis using Ago2 specific antibody revealed that CrPV-1A co-
immunoprecipitated with Ago2 (Fig. 4a, lane 4, right panel). In contrast, an antibody 
directed against Ago1 did not detect any Ago1 association with CrPV1A (Fig. 4a. lane 2, 
left panel), consistent with our results showing that CrPV-1A does not affect the Ago1-
dependent miRNA pathway. The Ago2 antibody used detected two Ago2 forms of 130 kDa 
and 95 kDa (Obbard et al., 2006). It is possible that the smaller form is the product of partial 
proteolysis during affinity tag purification, as we often detect 95 kDa isoform (Fig 4b and 
Fig 4c). To further analyze the interaction between CrPV-1A and Ago2, we transiently 
expressed CrPV-1A148-3FH and CrPV-1A108-3FH in S2 cells. While full length 
CrPV-1A148-3HF co-precipitated with Ago2, the truncated CrPV-1A108 was unable to 
interact with Ago2 (Fig 4b, lane 2). The interaction of CrPV-1A with Ago2 was further 
analyzed by two-step affinity purification from S2 extracts stably expressing 
CrPV-1A148-3FH. Commassie staining of the purified materials revealed the presence of 
only two distinct bands not present in the control sample (Supplementary Fig. 3). Mass-
spectroscopy analysis identified the two bands as CrPV-1A and Ago2. Furthermore, silver 
staining of CrPV-1A associated proteins uncovered no additional proteins (Fig. 4c, lane 2). 
These experiments suggested that CrPV-1A blocks catalytic activity of the RISC by direct 
interaction with endonuclease Ago2.
CrPV-1A acts on preassembled holo-RISC
The observation that CrPV-1A does not affect siRNA-RISC assembly in vitro (Fig. 3b), but 
nonetheless inhibits RISC cleavage activity (Fig. 3c), suggests that CrPV-1A interferes with 
the function of assembled holo-RISC. To directly test this possibility luciferase mRNA 
target cleavage assay was performed. S2 cell extracts were pre-incubated with duplex 
siRNA to allow holo-RISC assembly31–33 followed by recombinant CrPV-1A addition. We 
observed that CrPV-1A efficiently inhibited holo-RISC enzymatic activity even after 
assembly of holo-RISC (Fig. 5a, lane 3). As expected, DCV-1A and BSA control had no 
effect on pre-assembled RISC cleavage (Fig. 5a, lanes 4 and 5).
The ability of CrPV-1A to inhibit holo-RISC activity in vivo was also examined using the 
dual-luciferase reporter system in S2 cells expressing CrPV-1A under the control of an 
inducible metallothionein promoter (Fig 5b). Cells were co-transfected with plasmids 
expressing Renilla and firefly luciferase and dsRNA targeting firefly luciferase (dsLuc), or 
GFP (dsGFP) for 16 hrs to allow for maximal silencing of luciferase activity (Fig. 5b, 
dsLuc). Induction of CrPV-1A expression at 16 hrs resulted in near-complete restoration of 
firefly luciferase expression (Fig. 5b, dsLuc + CrPV-1A) compared to no CrPV-1A 
expression control (dsLuc). Together, these results indicate that CrPV-1A can efficiently 
inhibit pre-assembled holo-RISC function.
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Previous findings indicated that, in Drosophila, Ago2 is a component of active holo-RISC, 
which sediments with a ribosomal fraction following high-speed centrifugation 
(200,000×g)35. To examine whether CrPV-1A associates with active holo-RISC, 
cytoplasmic extracts from CrPV-1A expressing S2 cells were subjected to high-speed 
centrifugation to separate a high molecular weight fraction (P200) from supernatant (S200). 
Fractions were analyzed by immunoblot using antibodies that specifically recognize Ago2 
and CrPV-1A. Expression of CrPV-1A did not affect the distribution of Ago2 between the 
S200 and P200 fractions (Fig. 5d, α-Ago2). Furthermore, CrPV-1A expression did not affect 
siRNA association with the P200 fraction (Fig. 5d, northern blot, compare lanes 1, 2). 
Interestingly, CrPV-1A fractionates preferentially with the high molecular weight P200 
fraction, despite the fact that purified recombinant CrPV-1A migrates as a smaller soluble 
protein in gel filtration analysis (data not shown). We concluded that CrPV-1A neither 
induces Ago2 degradation nor causes disassembly of the holo-RISC, instead it is specifically 
recruited to the holo-RISC containing P200 fraction, where it exerts an inhibitory effect 
through binding to Ago2.
RNAi suppressors are virulence determinants
It is puzzling that two viruses with such overall homology as CrPV and DCV exhibit 
dramatically different virulence levels in natural infection12,13,18,19. Both DCV and CrPV 
induce high mortality in fruit flies by intra-thoracic injection in experimental laboratory 
condition21,22. In contrast, DCV causes mild and persistent infection while CrPV infection 
is highly lethal by oral inoculation 13,14,16,19,36,37. Furthermore in S2 cells, DCV 
establishes a persistent infection following an initial acute phase, while CrPV is highly lytic 
with no establishment of persistent infection (data not shown).
Virus pathogenesis is determined by many factors, including the ability of the virus to evade 
host immune response. Given the different properties of each suppressor, we considered 
whether they might determine the outcome of infection. Ideally, this hypothesis should be 
tested by engineering a virus carrying either of the different RNAi suppressors in an 
otherwise isogenic backgrounds. Given that no infectious clones are available for either 
DCV or CrPV, we examined the effect of CrPV-1A or DCV-1A in the context of a 
recombinant Sindbis virus infection. We engineered recombinant Sindbis viruses to express 
a green fluorescent protein (GFP) and RNAi suppressors CrPV-1A (Sin-CrPV148) or 
DCV-1A (Sin-DCV99) under the control of duplicated sub-genomic promoter (Fig. 6a)15. 
Control Sindbis viruses expressed inactive suppressors -- a truncated version of CrPV-1A 
(Sin-CrPV108) or DCV-1A carrying a mutation in the DSRM (Sin-DCVK73A)22. In 
addition to infecting insect cells, Sindbis also infects mammalian cells, which do not appear 
to use RNAi to control the virus, affording an unbiased control system for viral replication 
efficiency. No appreciable differences in virus replication kinetics were observed for these 
recombinant viruses in mammalian BHK-21 cells (Fig. 6b), indicating that expression of 
RNAi suppressors does not affect virus fitness in cells where the RNAi machinery does not 
play a major role in antiviral defense38.
Sindbis virus does not appear to encode an RNAi suppressor (data not shown) and 
establishes a persistent infection in Drosophila39. We thus determined the effect of 
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CrPV-1A and DCV-1A on Sindbis infection following intra-thorax inoculations in 
Drosophila. Both Sin-CrPV148 and Sin-DCV99 increased fly mortality as compared to the 
control virus expressing an inactive suppressor, Sin-CrPV108 (Fig. 6c). Consistent with the 
observation that CrPV-1A is a more effective RNAi suppressor than DCV-1A (Fig. 2a and 
2b), Sin-CrPV148 induced higher mortality in flies than Sin-DCV99 (Fig. 6c). This 
enhanced pathogenicity correlated with a dramatic increase in virus replication (Fig. 6d, α–
GFP and fluorescence AU). Strikingly, Sin-CrPV148 infection generated a broader GFP 
tissue distribution as seen in the thorax, abdomen, head, and legs of injected flies (Fig. 6d, i). 
Infection with control Sin-CrPV108 caused a localized GFP expression at the site of 
injection, suggesting that the absence of a functional suppressor limits both infectivity (Fig. 
6d, ii) and virus spread (Fig. 6d, i). We measured a modest increase in GFP expression 
during Sin-DCV99 infection that was localized predominately in the thorax, and to a lesser 
extent in the head of injected flies (Fig. 6d, ii). Quantification of GFP expression by western 
blot and fluorescence microscopy demonstrated that GFP expression was approximately 5 
fold higher in flies infected with Sin-CrPV148 as compared to Sin-DCV99 (Fig.6d, α–GFP 
and Fluorescence AU). GFP expression steadily increased during the first 10 days post Sin-
CrPV148 infection, at which point GFP levels remained constant (data not shown). 
Importantly, infected flies exhibited maximum GFP expression 10 days post Sin-DCV99 
infection followed by a gradual reduction in fluorescence, suggesting that flies were able to 
control the infection. We thus observed a striking correlation between the enhancement of 
Sindbis infection severity by CrPV-1A, the potency of this suppressor, and the virulence of 
natural CrPV infections. In contrast, DCV, which produces a moderate natural infection, 
carries a suppressor that causes a modest increase in Sindbis virulence. Taken together, these 
results indicated that these distinctly acting RNAi suppressors are virulence factors that 
determine the outcome of infection.
Discussion
RNA interference (RNAi) can provide sequence specific antiviral immunity in plants and 
insects40–42. To counteract this antiviral mechanism, viruses have evolved suppressor 
proteins with RNAi-modulating activity. We here identified a unique mode of action 
employed by CrPV for suppressing RNAi-based antiviral immunity. This suppression 
activity mapped to the N-terminal region of CrPV ORF1, encoding the protein CrPV-1A. 
We find that CrPV-1A specifically interacts with Ago2 in the context of preassembled holo-
RISC and can potently suppress RNAi in Drosophila.
The mechanism of CrPV-1A is different from RNAi suppressors from FHV (B2) and DCV 
(1A), which appear to prevent viral dsRNA processing by Dicer 2 and siRNAs to assemble 
into RISC 2,11. This widely used strategy presumably relies on physical shielding of viral 
dsRNAs from the RNAi machinery. In contrast, CrPV-1A, shows no detectable RNA 
binding affinity (Supplementary Fig. 2) and does not prevent the loading of siRNAs (Fig. 
3b, Fig. 5d) or the formation of holo-RISC (Fig. 3b, Fig. 5d). We find that CrPV-1A 
interacts with Ago2 (Fig 4c) and inhibits RISC activity in vivo and in vitro without affecting 
Dicer processing or RISC assembly (Fig. 3–5). CrPV-1A, in the absence of other viral 
proteins, is preferentially recruited to high molecular weight pre-assembled holo-RISC 
fractions containing Ago2 and siRNAs (Fig. 5d), and inhibits holo-RISC catalytic activity 
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following RISC pre-formation and assembly (Fig. 5a). In principle, additional CrPV-1A 
functions within the CrPV replication cycle cannot be excluded, given the multifunctional 
nature of many viral proteins. However, the fact that CrPV-1A alone both inhibits RNAi and 
suffices to strongly enhance pathogenicity of the evolutionarily unrelated Sindbis virus 
demonstrates that CrPV-1A is itself an RNAi suppressor with an autonomous pathogenesis 
modulating function, which is transferable to other viruses.
While the existence of virus-encoded RNAi suppressors in animals is now firmly 
documented, relatively little is known about how these factors intersect with host functions 
and how they contribute to the overall balance between viral replication and transmission. 
Comparison of RNAi suppression strategies of two closely related viruses, DCV and CrPV, 
yield insights into both issues. Notably, we find that both viruses are specific for the host 
siRNA pathway, as neither CrPV-1A nor DCV-1A affected the miRNA gene-silencing 
pathway (Fig. 2). Indeed, CrPV-1A suppresses the siRNA-mediated gene-silencing pathway 
by selectively interacting with Ago2, and not related Ago1 homolog (Fig 4a) involved in 
miRNA-mediated RISC function. Both DCV and CrPV affect the esiRNA mediated 
retrotransposons silencing by virtue of their abilities to counteracts the functions of Dicer2 
and Ago2 respectively (Fig 2f). These observations contrast with known plant virus RNAi 
suppressors, which do not discriminate between the siRNA and miRNA pathways9,25,43. 
Due to aberrations in the miRNA pathway during infection, plant viruses often cause 
physiological and developmental abnormalities within the host9,25,43. The difference 
between plant and animal viruses may be explained by the interdependent nature of the plant 
siRNA and miRNA pathways as opposed to the distinctly separate pathways observed in 
Drosophila melanogaster3. Since miRNAs are important for host physiology and 
development, the selectivity in RNAi suppression in insect viruses may afford them an 
evolutionary advantage. By controlling the host RNAi antiviral response without perturbing 
normal host physiology, viruses may replicate efficiently and establish a persistent infection, 
as well as facilitating vertical transmission of the virus to the host progeny. These strategies 
would ensure virus transmission and survival within a host population.
DCV and CrPV are closely related viruses within the Dicistroviridae family. While both 
viruses encode RNAi suppressor at N-terminus of their genomes, these suppressors exhibit 
very different mechanisms of action and RNAi suppressor potency. Our data suggests that 
their potency for inhibition of the host antiviral defense contributes to their differential 
pathogenicity. Indeed, engineering Sindbis virus to carry DCV-1A and CrPV-1A altered the 
pathogenicity of an otherwise benign Sindbis infection in flies to an acute one of varying 
severity. Since both RNAi suppressors were expressed within the same site of the Sindbis 
virus, using the same promoter and in the absence of other CrPV or DCV proteins, these 
experiments provide a direct readout of the link between their autonomous RNAi suppressor 
function and pathogenicity. The expression of the more potent RNAi suppressor, CrPV-1A, 
significantly enhanced Sindbis virus pathogenicity and correlated with a dramatic increase in 
virus replication and fly mortality. On the other hand Sin-DCV99 was only partially more 
pathogenic. It is tempting to speculate that the differential potency of the CrPV and DCV 
RNAi suppressors stems from their very different modes of action. DCV-1A relies on 
nonspecific RNA binding activity to protect long dsRNA from Dicer2 processing. Complete 
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RNAi inhibition likely requires high levels of DCV-1A production to saturate all Dicer2 
processing sites. In contrast, CrPV-1A acts by directly inhibiting the catalytic component of 
RISC (Fig. 5e), a multi-turn over enzyme44. Thus, inhibition of the siRISC by CrPV-1A 
may provide a more efficient strategy to prevent viral genome degradation, which may lead 
to high viral titer production.
The differential potency of the RNAi suppressors of DCV and CrPV, and their differential 
effects on Sindbis pathogenicity resonate with the very different types of infection caused by 
these otherwise very similar viruses. CrPV is a highly lytic virus that induces substantial 
mortality in flies19. In contrast, DCV, in nature, establishes a symbiotic, chronic infection in 
Drosophila without causing appreciable mortality12,13,16,45. Indeed, DCV was first found 
in field populations by random screening of the flies and not as a result of any particular 
syndrome13. Given that the pathogenic characteristics of DCV and CrPV infection are 
replicated by simply transferring the respective RNAi suppressors to Sindbis, we argue that 
these proteins are attuned with the natural virus infection strategy. For instance, the chronic, 
persistent infection of Drosophila characterized by DCV may be attributed to the modest 
RNAi suppressing activity exhibited by DCV-1A. Our results point to an exquisite 
equilibrium between the host antiviral defense machinery and the viral RNAi suppressors 
that serves as an evolutionary fine tune of the host-virus interactions and determines the 
pathogenic outcome of infection, virus survival, and virus spread.
Methods
RNAi reporter assay
We cultured Drosophila S2 cells (Supplementary Fig. 4), on 96 well plates. We transfected 
S2 cells with plasmids encoding CrPV-1A or infected with CrPV (MOI 1) and carried out 
RNAi reporter assay as described22. We tested the effect of CrPV-1A on microRNA 
(miRNA) miR2b function as described22. We designed antisense oligonucleotides (ASO) 
against endogenous miR2b46and transfected in to S2 cells using Dharmafect 4 reagent 
(Dharmacon) for 48 hrs followed by co-transfection of the reporter systems. We synthesized 
2’-O-Me 3’ cholesterol modified miR-2b ASO 
(C.A.A.A.U.G.C.U.C.C.U.C.A.A.A.G.C.U.G.G.C.U.G.U.G.A.U.A.A.U.U.C.U.3'-Chl) from 
Dharmacon.
Dicer assay
We performed Dicer assay in S2 cell extracts as described22,34. We incubated recombinant 
DCV-1A, CrPV-1A or BSA in the reaction for 10 min followed by addition of uniformly 
labeled 200 bp GL3 dsRNA (105 cpm) for 3 hrs at 25°C.
Slicer assay
We performed RISC cleavage assays as described33 using a 5’ capped FLuc mRNA target 
(592 nt) with a specific siRNA that generates a 100nt 5’ cleaved product. We either used 
CrPV or DCV infected S2 extract or supplemented recombinant CrPV-1A and DCV-1A in 
uninfected S2 extract. We performed a 35 µl reaction (40% v/v S2 extracts) for 3hr at 25°C.
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Assembly assay
We performed RISC assembly experiments as described31,32. We incubated recombinant 
suppressor protein in embryo extract for 10 min, subsequently we added 32P-radiolabeled 
siRNA duplex to the reaction for another 20 min. The 5µl reactions contained 40% v/v 
embryo lysates.
Generation of stable S2 cell lines
We cloned CrPV-1A in frame with C-terminal 3xFLAG and 6xHis tags in vector pMT/V5-
HisA (Invitrogen). We generated stable cell lines according to manufacturer’s instruction 
(Invitrogen). We induced the expression of the protein with 500 µM CuSO4 for 20 hrs.
Immunoprecipitation
We transfected plasmids pAc-CrPV148-3FH, pAc-CrPV108-3FH, pAc5.1-V5/HisA vector 
(Invitrogen) into S2 cells (1×107 cells) for 24 hour, resuspended cells in IP buffer [30mM 
Hepes pH 7.4, 150mM KOAc, 2mM MgOAc, 5mM DTT, 0.1% NP-40, protease inhibitor 
tablet (Roche)] and sonicated on ice. We centrifuged (14,000×g) and added supernatant to 
magnetic beads (Dynal) conjugated with anti-Flag M2 antibody. We washed beads and 
boiled in SDS sample buffer at 95°C for 5 min. We ran eluted sample in 4–20% gradient 
SDS-PAGE gel, transferred to PVDF membrane and probed with Drosophila Ago1 or Ago2 
antibodies. We followed the purification profile by western blot (Supplementary Fig. 5)
Suppressor-Argonaute 2 complex purification
We resuspended two grams of either induced or uninduced stable S2 cells in 1ml IP buffer 
and ground into powder in a mortar and pestle under liquid nitrogen. We prepared crude 
extracts by adding 9ml IP buffer to ground S2 cell and homogenized for 2 min on ice. We 
centrifuged (14,000×g) and added supernatant to anti-Flag M2 antibody conjugated 
magnetic beads (Invitrogen), washed with IP buffer and eluted using IP buffer with 3X Flag 
peptide (400 µg ml−1)(Sigma). We added eluted sample to Talon magnetic beads 
(Invitrogen), washed with IP buffer and eluted in IP buffer containing 250 mM Imidazole. 
We stained eluted material with sliver according to manufacturer’s instruction (Invitrogen). 
To determine the expression profile of Ago2 and CrPV-1A in stable S2 cells we followed 
the one step (Flag IP) purification protocol and analyzed by western blot analysis 
(Supplementary Fig. 5).
Protein Identification
We resolved eluted sample on a 4–20% gradient gel and stained using coomassie brilliant 
blue (Sigma). We excised protein bands and destanined followed by in gel trypsin digestion. 
We analyzed the trypsin generated peptide fragments using modular mass spectrometric 
tool, which includes several MALDI-MS and MALDI-MS/MS mass spectrometer as well as 
an HPLC-MS/MS mass spectrometer47.
Expression and purification of recombinant proteins
We cloned CrPV-1A in to pHis-Gb1-II vector48, transformed into BL21DE3 cells and 
purified His-tag fusion protein using Ni-NTA resin (Qiagen). We purified GST-DCV-1A as 
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described22. Polyclonal antibody against CrPV-1A was raised in rabbits immunized with 
purified recombinant proteins. Expression of full-length Drosophila Argonaute 1 in E.coli 
was carried out as described for CrPV-1A.
RNAi in Fly
We established transgenic flies expressing CrPV-1A in developing eye as described22. We 
performed eye pigment determination assays on 3 days virgin females49. We established 
microRNA sensor lines expressing CrPV-1A as below. We recombined P[Tub-bantam 
sensor]26 transgenic stocks by genetic crosses with the P[engrailed-Gal4] line27 to obtain 
the homozygous w1118 ; II P[engrailed-Gal4] ; III P[Tub-bantam sensor] miRNA bantam 
sensor line. We crossed homozygous P[pUAS-CrPV-148], P[pUAS-CrPV108] and w1118 
stocks to the sensor line. We dissected wing imaginal discs from third instar larvae fixed in 
4% formaldehyde, and stained with mouse monoclonal anti-GFP (Roche) to visualize sensor 
expression using Apotome microscopy. To observe the effect of RNAi suppressors on retro-
transposons expression, we made transgenic flies expressing CrPV-1A as described50. We 
measured the expression levels of 412, mdg1 and 297 transposon in double heterozygous 
UASp>VSR; da>GAL4 and control heterozygous da>GAL4 2-days old females. We 
manually separated fifty heads and processed for total RNA extraction and reverse 
transcription. We analyzed Transposon levels by real-time PCR using primers as described 
28,29,50.
Holo-RISC fractionation
We transfected 20 µg dsRNA (200 bp FLuc dsRNA) in to stable S2 cells (1×107) using 
Effectene reagent (Qiagen). After 48 hr, cells were induced with CuSO4 for additional 20 
hrs. We performed Holo-RISC purification as described 35. We resuspended cells in 
hypotonic buffer (10 mM Hepes pH 7.4 and 6 mM β-mercaptoethanol), lysed by passing 
through insulin syringe, spun down at 14,000×g for 25 min at 4°C. We centrifuged the post-
nuclear, cytoplasmic extract at 200,000 ×g for 3hrs at 4°C to separate the ribosomal pellet 
(P200) from supernatant (S200). We probed P200 and S200 fraction for Argonaute 2 and 
CrPV-1A by western blot.
Northern blotting
We treated ribosomal pellet (P200) with 1mM MgCl2 and 400mM KOAc. We centrifuged 
extracted soluble material at 100,000×g for 1 hr at 4°C. We treated the supernatant with 
SDS and proteinase K and extracted RNA with phenol. We resolved small RNA on 12% 
Urea-gel, transferred onto Hybond-N+ nylon membrane (Amersham Biosciences) and 
hybridized with Fluc sense strand riboprobe.
Recombinant Sindbis virus production and Fly injection
We generated Sindbis virus expressing RNAi suppressor CrPV-1A and DCV-1A as 
described15. We determined growth kinetics of viruses in BHK 21 cells. We injected five-
day-old female flies in the thorax with 50 nl of virus (2500–5000 PFU) using a nanoinjector 
(Nanoject II, Drummond Scientific). We observed GFP expression in flies by GFP 
microscopy and western blot analysis. We incorporated GFP images per group of flies (4–5 
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each) into the Volocity software (Improvision, UK) under the measurement module. We 
used non-injected flies as background for further calculation. To determine the pathogenicity 
of DCV in transgenic flies expressing CrPV-1A and DCV-1A, we injected 100 TCID50 of 
DCV by intra-thoracic injection as described22.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Judith Frydman (Stanford University) and member of the Andino laboratory Leonid Gitlin, Dwight 
Barnes, Michelle Flenniken and Adam Lauring for useful discussion for preparing the manuscript. Special thank to 
Ronald van Rij (Nijmegen Centre for Molecular Life Sciences, the Netherlands) and Carla Saleh (Institut Pasteur, 
France) for their help. We thank Dr Graham Belsham (National Veterinary Institute, Denmark) for critical reading 
of the manuscript and useful comments. We are grateful to Phil Zamore (UMass Medical School), Mikiko Siomi 
and Keita Miyoshi (Keio University School of Medicine, Japan) for providing antibody directed against Drosophila 
Argonaute 2, Hans Heidner for providing Sindbis virus plasmid (University of Texas, San Antonio) and Michelle 
Moritz (UCSF) for Drosophila embryo extract preparation. This work was financially supported by Pasteur 
Institute, the CNRS and by grants from ANR (AKROSS) and from ARC to C.A., and by NIH grants AI40085 and 
AI064738 to R.A.
References
1. Siomi H, Siomi MC. On the road to reading the RNA-interference code. Nature. 2009; 457:396–
404. [PubMed: 19158785] 
2. van Rij RP, Andino R. The silent treatment: RNAi as a defense against virus infection in mammals. 
Trends Biotechnol. 2006; 24:186–193. [PubMed: 16503061] 
3. Forstemann K, Horwich MD, Wee L, Tomari Y, Zamore PD. Drosophila microRNAs are sorted into 
functionally distinct argonaute complexes after production by dicer-1. Cell. 2007; 130:287–297. 
[PubMed: 17662943] 
4. Tomari Y, Du T, Zamore PD. Sorting of Drosophila small silencing RNAs. Cell. 2007; 130:299–
308. [PubMed: 17662944] 
5. Ding SW, Voinnet O. Antiviral immunity directed by small RNAs. Cell. 2007; 130:413–426. 
[PubMed: 17693253] 
6. Baumberger N, Tsai CH, Lie M, Havecker E, Baulcombe DC. The Polerovirus silencing suppressor 
P0 targets ARGONAUTE proteins for degradation. Curr Biol. 2007; 17:1609–1614. [PubMed: 
17869110] 
7. Bortolamiol D, Pazhouhandeh M, Marrocco K, Genschik P, Ziegler-Graff V. The Polerovirus F box 
protein P0 targets ARGONAUTE1 to suppress RNA silencing. Curr Biol. 2007; 17:1615–1621. 
[PubMed: 17869109] 
8. Pazhouhandeh M, et al. F-box-like domain in the polerovirus protein P0 is required for silencing 
suppressor function. Proc Natl Acad Sci U S A. 2006; 103:1994–1999. [PubMed: 16446454] 
9. Zhang X, et al. Cucumber mosaic virus-encoded 2b suppressor inhibits Arabidopsis Argonaute1 
cleavage activity to counter plant defense. Genes Dev. 2006; 20:3255–3268. [PubMed: 17158744] 
10. Kasschau KD, et al. P1/HC-Pro, a viral suppressor of RNA silencing, interferes with Arabidopsis 
development and miRNA unction. Dev Cell. 2003; 4:205–217. [PubMed: 12586064] 
11. Chao JA, et al. Dual modes of RNA-silencing suppression by Flock House virus protein B2. Nat 
Struct Mol Biol. 2005; 12:952–957. [PubMed: 16228003] 
12. Gomariz-Zilber E, Thomas-Orillard M. Drosophila C virus and Drosophila hosts: a good 
association in various environments. Journal of Evolutionary Biology. 1993; 6:677–689.
13. Brun, P.; Plus, N. The Genetics and Biology of Drosophila. Vol. Vol 2d. New York: Academic 
Press; 1980. The viruses of Drosophila; p. 625-702.
Nayak et al. Page 14
Nat Struct Mol Biol. Author manuscript; available in PMC 2013 November 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
14. Jousset F-X, Plus N. Etude de la transmission horizontale et de la transmission verticale de 
Picornavirus de Drosophila melanogaster et de Drosophila immigrans. Ann Microbiol (Inst 
Pasteur). 1975; 126:231–249.
15. Thomas JM, Klimstra WB, Ryman KD, Heidner HW. Sindbis virus vectors designed to express a 
foreign protein as a cleavable component of the viral structural polyprotein. J Virol. 2003; 
77:5598–5606. [PubMed: 12719552] 
16. Aravin AA, et al. The small RNA profile during Drosophila melanogaster development. Dev Cell. 
2003; 5:337–350. [PubMed: 12919683] 
17. Gomariz-Zilber E, Poras M, Thomas-Orillard M. Drosophila C virus: experimental study of 
infectious yields and underlying pathology in Drosophila melanogaster laboratory populations. J 
Invertebr Pathol. 1995; 65:243–247. [PubMed: 7745279] 
18. Reinganum C. The isolation of cricket paralysis virus from the emperor gum moth, Antheraea 
eucalypti Scott, and its infectivity towards a range of insect species. Intervirology. 1975; 5:97–
102. [PubMed: 1184353] 
19. Manousis T, Moore NF. Cricket Paralysis Virus, a Potential Control Agent for the Olive Fruit Fly, 
Dacus oleae Gmel. Appl Environ Microbiol. 1987; 53:142–148. [PubMed: 16347255] 
20. Wilson JE, Powell MJ, Hoover SE, Sarnow P. Naturally occurring dicistronic cricket paralysis 
virus RNA is regulated by two internal ribosome entry sites. Mol Cell Biol. 2000; 20:4990–4999. 
[PubMed: 10866656] 
21. Galiana-Arnoux D, Dostert C, Schneemann A, Hoffmann JA, Imler JL. Essential function in vivo 
for Dicer-2 in host defense against RNA viruses in drosophila. Nat Immunol. 2006; 7:590–597. 
[PubMed: 16554838] 
22. van Rij RP, et al. The RNA silencing endonuclease Argonaute 2 mediates specific antiviral 
immunity in Drosophila melanogaster. Genes Dev. 2006; 20:2985–2995. [PubMed: 17079687] 
23. Wang XH, et al. RNA interference directs innate immunity against viruses in adult Drosophila. 
Science. 2006; 312:452–454. [PubMed: 16556799] 
24. Hahn H, Palmenberg AC. Mutational analysis of the encephalomyocarditis virus primary cleavage. 
J Virol. 1996; 70:6870–6875. [PubMed: 8794329] 
25. Chapman EJ, Prokhnevsky AI, Gopinath K, Dolja VV, Carrington JC. Viral RNA silencing 
suppressors inhibit the microRNA pathway at an intermediate step. Genes Dev. 2004; 18:1179–
1186. [PubMed: 15131083] 
26. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. bantam encodes a developmentally 
regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in 
Drosophila. Cell. 2003; 113:25–36. [PubMed: 12679032] 
27. Roignant JY, et al. Absence of transitive and systemic pathways allows cell-specific and isoform-
specific RNAi in Drosophila. Rna. 2003; 9:299–308. [PubMed: 12592004] 
28. Czech B, et al. An endogenous small interfering RNA pathway in Drosophila. Nature. 2008; 
453:798–802. [PubMed: 18463631] 
29. Ghildiyal M, et al. Endogenous siRNAs derived from transposons and mRNAs in Drosophila 
somatic cells. Science. 2008; 320:1077–1081. [PubMed: 18403677] 
30. Kawamura Y, et al. Drosophila endogenous small RNAs bind to Argonaute 2 in somatic cells. 
Nature. 2008; 453:793–797. [PubMed: 18463636] 
31. Miyoshi K, Tsukumo H, Nagami T, Siomi H, Siomi MC. Slicer function of Drosophila Argonautes 
and its involvement in RISC formation. Genes Dev. 2005; 19:2837–2848. [PubMed: 16287716] 
32. Pham JW, Sontheimer EJ. Molecular requirements for RNA-induced silencing complex assembly 
in the Drosophila RNA interference pathway. J Biol Chem. 2005; 280:39278–39283. [PubMed: 
16179342] 
33. Sontheimer EJ. Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol. 
2005; 6:127–138. [PubMed: 15654322] 
34. Haley B, Tang G, Zamore PD. In vitro analysis of RNA interference in Drosophila melanogaster. 
Methods. 2003; 30:330–336. [PubMed: 12828947] 
35. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-
transcriptional gene silencing in Drosophila cells. Nature. 2000; 404:293–296. [PubMed: 
10749213] 
Nayak et al. Page 15
Nat Struct Mol Biol. Author manuscript; available in PMC 2013 November 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
36. Thomas-Orillard M, Legendre S. [C virus of Drosophila and dynamics of host population]. C R 
Acad Sci III. 1996; 319:615–621. [PubMed: 9011323] 
37. Plus N, Croizier G, Jousset FX, David J. Picornaviruses of laboratory and wild Drosophila 
melanogaster: geographical distribution and serotypic composition. Ann Microbiol (Paris). 1975; 
126:107–117. [PubMed: 811144] 
38. Cullen BR. Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat 
Immunol. 2006; 7:563–567. [PubMed: 16715068] 
39. Mudiganti U, Hernandez R, Ferreira D, Brown DT. Sindbis virus infection of two model insect cell 
systems--a comparative study. Virus Res. 2006; 122:28–34. [PubMed: 16854488] 
40. Hannon GJ. RNA interference. Nature. 2002; 418:244–251. [PubMed: 12110901] 
41. Voinnet O. RNA silencing as a plant immune system against viruses. Trends Genet. 2001; 17:449–
459. [PubMed: 11485817] 
42. Zamore PD. RNA interference: listening to the sound of silence. Nat Struct Biol. 2001; 8:746–750. 
[PubMed: 11524674] 
43. Merai Z, et al. Double-stranded RNA binding may be a general plant RNA viral strategy to 
suppress RNA silencing. J Virol. 2006; 80:5747–5756. [PubMed: 16731914] 
44. Haley B, Zamore PD. Kinetic analysis of the RNAi enzyme complex. Nat Struct Mol Biol. 2004; 
11:599–606. [PubMed: 15170178] 
45. Vaidyanathan R, Scott TW. Apoptosis in mosquito midgut epithelia associated with West Nile 
virus infection. Apoptosis. 2006; 11:1643–1651. [PubMed: 16820968] 
46. Horwich MD, Zamore PD. Design and delivery of antisense oligonucleotides to block microRNA 
function in cultured Drosophila and human cells. Nat Protoc. 2008; 3:1537–1549. [PubMed: 
18802435] 
47. Blethrow JD, Tang C, Deng C, Krutchinsky AN. Modular mass spectrometric tool for analysis of 
composition and phosphorylation of protein complexes. PLoS ONE. 2007; 2:e358. [PubMed: 
17406682] 
48. Harper SM, Neil LC, Gardner KH. Structural basis of a phototropin light switch. Science. 2003; 
301:1541–1544. [PubMed: 12970567] 
49. Ephrussi B, Herold JL. Studies of Eye Pigments of Drosophila. I. Methods of Extraction and 
Quantitative Estimation of the Pigment Components. Genetics. 1944; 29:148–175. [PubMed: 
17247114] 
50. Berry B, Deddouche S, Kirschner D, Imler JL, Antoniewski C. Viral suppressors of RNA silencing 
hinder exogenous and endogenous small RNA pathways in Drosophila. PLoS One. 2009; 4:e5866. 
[PubMed: 19516905] 
Nayak et al. Page 16
Nat Struct Mol Biol. Author manuscript; available in PMC 2013 November 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Cricket paralysis virus (CrPV) antagonizes RNAi in S2 cells. (a) CrPV infected S2 cells or 
uninfected S2 cells were co-transfected with firefly, renila luciferase plasmid and either 
double stranded RNA (dsRNA) targeting the firefly luciferase (Luc) or eGFP dsRNA 
control (Ctrl). Silencing efficiency in S2 cells were monitored by comparing the ratio of 
firefly to renila luciferase expression. (b) CrPV genome encodes both non-structural and 
structural proteins whose translation is regulated by internal ribosome entry site (IRES) 1 
and 2 respectively. The extended broken line (−) represents alignment of the viral suppressor 
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of RNA silencing (VSR) domains that include N-terminal 180 amino acid of the CrPV 
ORF1 and 111 amino acid of the DCV ORF1. - indicates gap, * indicates complete 
homology, red open box represents the conserved octameric sequence, ↓ indicates non-
proteolytic cleavage site, and Δ indicates sites of deletion in the VSR region (c) S2 cells 
were either mock (Unif) or CrPV infected (at MOI 1) for 24hrs and 48 hrs. Harvested 
samples were analyzed for 1A expression by western blot analysis using rabbit polyclonal 
antibody raised against the suppressor protein (α-CrPV-1A). (d) Plasmids encoding C-
terminal amino acid deletion of putative CrPV suppressor domain (168,148,128,108) were 
cotransfected with dual luciferase reporter system along with FLuc dsRNA targeting firefly 
luciferase or eGFP dsRNA control as described in figure a. Silencing was represented as 
fold silencing compared to the control dsRNA. Data in (a) and (d) indicate averages and 
standard deviations of four independent experiments.
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Figure 2. 
CrPV-1A is a potent RNAi suppressor and does not interfere in the microRNA pathway. (a) 
Transgenic flies expressing CrPV-1A148 or CrPV-1A108, or DCV-1A99 or GFP and an 
inverted repeat [IR] directed against the white gene were analyzed for their ability to carry 
out efficient RNAi. Loss of red eye pigments in presence of indicated suppressor proteins is 
expressed as % silencing compared to GFP control fly. (b) Transgenic flies expressing 
CrPV-1A and DCV-1A were injected intra-thoracically with 100 TCID50 DCV or Tris 
buffer control and survival rate was monitored daily. (c) Luciferase reporter plasmid 
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carrying miR2b target sequences in sense and antisense orientation (Supplementary Fig. 1b) 
in the 3’ untranslated region (UTR) was transfected into S2 cells. Luciferase expression in 
presence of CrPV-1A, DCV-1A was expressed as ratio of luciferase counts produced by 
luciferase miR2b antisense over luciferase miR2b sense reporter transfection. (d) S2 cells 
were transfected with miR-2b ASO followed by trasnsfection of reporter system (miR2b 
antisense). miR-2b ASO restored luciferease expression up to 50% compared to Ctrl ASO 
(e) The effect of CrPV-1A on bantam mediated translational repression in the imaginal disc 
was analyzed in flies expressing GFP mRNA containing three complementary bantam 
miRNA target sites. (f) Fold changes in retrotransposons RNA levels were calculated 
relative to 297, mdg1 and 412 RNA levels measured in control flies. Fold changes in 
homozygous Ago2414 mutants were calculated relative to heterozygous ago2414 flies. Data 
in (a), (c), (d) and (f) indicate standard deviations from three independent experiments.
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Figure 3. 
CrPV-1A inhibits RISC activity downstream of Dicer processing. (a) Radio-labeled dsRNA 
substrates (32P-dsRNA) were incubated in S2 buffer control (lane 1) or in S2 extracts (lane 
2). Processing of long dsRNA to siRNA by Dicer2 in presence of recombinant CrPV-1A 
(0.35 µM, lane 3), DCV-1A (0.35 µM, lane 5) or bovine serum albumin (BSA) (0.35 µM, 
lane 4) was monitored using 12% denaturing gel with an end-labeled 21bp synthetic siRNA 
marker. (b) Recombinant suppressor proteins DCV-1A (0.35 µM, lane 2), CrPV-1A (0.35 
µM, lane 3) or BSA protein (0.35 µM, lane 4) were incubated in Drosophila embryo extract 
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for 10 min. 32P-labeled siRNAs duplex were subsequently added to the reaction for another 
20 min. siRNP complexes (R1, R2 and R3) were analyzed by electrophoretic mobility shift 
assay (EMSA) using 4% native polyacrylamide gel electrophoresis. (c) Target mRNA 
cleavage assay was analyzed in absence of siRNA (lane 1), in presence of GAPDH (Ctrl) 
siRNA (lane 2) or Luc siRNA (lane 3-lane 11). To analyze the effects of CrPV-1A, assays 
were carried out using CrPV infected S2 extracts (MOI 1 and MOI 2) in lane 4, lane 5 or by 
incubating recombinant CrPV-1A with increasing concentration (0.15 µM, lane 6), (0.25 
µM, lane 7), (0.35 µM, lane 8) in uninfected S2 extracts. The activity of the DCV-1A was 
analyzed using infected DCV S2 extracts (MOI 1, lane 10) or by incubating recombinant 
DCV-1A (0.35 µM, lane 11) in uninfected S2 extracts. The 5’ cleaved products were 
analyzed by denaturing polyacrylamide gel.
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Figure 4. 
CrPV-1A interacts with Argonaute 2 in S2 cells. (a) S2 cells were transfected with plasmids 
transiently expressing CrPV-1A-3FH (lane 2, 4) or empty vector control (lane 1, 3). Flag-
His tagged CrPV-1A was immunopurified with anti-Flag antibody and western blotted with 
Drosophila Argonaute 2 (α-Ago2, right panel) or Argonaute 1 (α-Ago1, left panel) 
polyclonal antibodies. Two isoforms of Ago2 (Ago2a and Ago2b) were detected with Ago2 
specific antibodies. Asterisks (*) indicate cross-reacting host-protein band. Lane 6 and 8 
show the positive detection of E.coli expressed Drosophila Ago1 and endogenous 
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Drosophila Ago2 with Ago1 and Ago2 antibody respectively (Ab control). (b) Flag-His 
tagged CrPV-1A148, CrPV-1A108 were transfected in to S2 cells, immunopurified using 
anti-Flag antibody and probed with Ago2 antibody (α-Ago2). To detect the expression of 
1A protein, the blot was stripped and further probed with anti-Flag antibody (α-Flag) (lane 3 
and lane 4, bottom panel). Asterisks (*) indicates a cross-reacting host-protein band (c) 
Stable S2 cell lines either expressing CrPV-1A-3FH (induced with CuSO4) or uninduced 
control was lysed, immunopurified with anti-Flag antibody followed by Talon magnetic 
bead purification. The silver stained gel shows the co-purification of the CrPV-1A and 
Argonaute 2 (Ago2b isoform) from S2 cells (right lane). Left lane represents the molecular 
weight marker. Asterisk (*) indicates non-specific contaminant band (see Supplementary 
figure 3).
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Figure 5. 
CrPV-1A interferes with the function of pre-programmed holo-RISC in vitro and in vivo. (a) 
S2 extracts were programmed with siRNA for 45 min followed by addition of 1A [(0.35 µM 
CrPV-1A, lane 3), (0.35 µM DCV-1A, lane 4) or (BSA, lane 5)] for 10 min. RISC assay was 
initiated by incubating 32P-mRNA substrate for additional 3hrs and 5′ cleaved product was 
analyzed using denaturing polyacrylamide gel electrophorsis (PAGE). (b) Silencing of 
firefly luciferase in stable S2 cells was programmed by co-transfecting firefly and renila 
reporter plasmid with specific FLuc dsRNA (dsLuc) or control eGFP dsRNA (dsGFP). 16 
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hrs post-transfection, luciferase expression was monitored either in presence (dsLuc
+CrPV-1A, dsGFP+ CrPV-1A) or absence (dsLuc) of CrPV-1A for a period of 24 hrs. (c) 
Stable S2 cells were transfected with FLuc dsRNA for 48 hrs followed by induction of 
suppressor for additional 20 hrs. The post-nuclear cytoplasmic extract was centrifuged at 
200,000×g to separate the ribosomal pellet (P200) from the supernatant (S200). (d) P200 and 
S200 fractions were western blotted using Drosophila Argonaute 2 (α-Ago2) polyclonal and 
anti-Flag (α-Flag) monoclonal antibodies. RNA extracted from P200 fraction was analyzed 
for Luc siRNA by northern blot. P200 ethidium bromide (Et. Br) represents RNA isolated 
from soluble high salt P200 extraction. (e) DCV-1A and FHV B2 either inhibits Dicer 2 
processing of long dsRNA or siRNA incorporation in to RISC by virtue of their dsRNA or 
siRNA binding activity. Conversely, CrPV-1A acts at the level of holo-RISC by protein-
protein interaction with Drosophila Argonaute 2.
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Figure 6. 
RNAi suppressors determine spread and pathogenesis of Sindbis virus in fruit fly. (a) 
Expression of the Sindbis virus structural proteins is regulated by a sub-genomic promoter 
(Pr1). CrPV-1A and DCV-1A were cloned under the control of a duplicated subgenomic 
promoter (Pr2) in the 3’ untranslated region (UTR) of the sindbis genome. These 
recombinant viruses also express green fluorescence protein (GFP) that cleaves at both N 
and C- terminus during structural polyprotein processing15. (b) BHK cells were infected 
with recombinant Sindbis viruses at MOI 1, virus sample were collected over a period of 24 
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hrs (h). Titer of the each sample [plaque forming unit (PFU) per ml] was measured by 
plaque assay and replication kinetics of each virus was determined. (c) Intrathoracic 
injections of flies with engineered Sindbis virus expressing CrPV-1A (Sin-CrPV148) 
induced higher mortality and tissue spread at similar dose of infection (2500–5000 PFU) 
compared to Sindbis virus expressing DCV-1A (Sin-DCV99). Survival rate of flies (%) was 
monitored daily (d) for thirty days. (d) (i) Flies injected with recombinant Sindbis viruses 
(Sin-CrPV148, Sin-CrPV108, Sin-DCV99 and Sin-DCVK73A) were imaged by GFP 
microscopy. For western blot analysis 4–5 flies from each injection at 11 days post infection 
were homogenized and blotted with anti-GFP antibodies (α-GFP). The same blot was 
stripped and probed with anti-actin antibody (α-actin). (ii) GFP fluorescence (AU) for 
recombinant Sindbis viruses (Sin-CrPV148, Sin-CrPV108, Sin-DCV99) was measured and 
data represents the means and standard error of the mean for 4–5 individual flies.
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